Annual report pursuant to section 13 and 15(d)

2. Summary of significant accounting (Details Narrative)

v2.4.0.6
2. Summary of significant accounting (Details Narrative)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Stock Options
   
Antidilutive shares excluded from earnings per share 27,278,098 24,067,892
Warrant [Member]
   
Antidilutive shares excluded from earnings per share 42,205,507 49,106,280
Convertible Notes
   
Antidilutive shares excluded from earnings per share 0 6,836,016